Vital Biopharmaceutical Insights and Analytics
for Experts from Experts
Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
Learn More
The irritable bowel syndrome drug market will more than triple from $459 million in 2008 to $1.52 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan ...Learn More
Featured Webinar
Will the Lack of Efficacious Therapies Open the Door for a New Clinical Gold Standard in Obesity Treatment?
March 17, 2010...Learn More
View Webinar schedule and archive